日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy

抗 PD-1 治疗后肾移植排斥反应中同种异体反应性 T 细胞的克隆动态

Garrett S Dunlap, Daniel DiToro, Joel Henderson, Sujal I Shah, Mike Manos, Mariano Severgnini, Astrid Weins, Indira Guleria, Patrick A Ott, Naoka Murakami #, Deepak A Rao #

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors

OX40(ivuxolimab)和 4-1BB(utomilumab)激动剂抗体组合在晚期实体瘤患者中的首次人体研究

Omid Hamid, Alberto A Chiappori, John A Thompson, Toshihiko Doi, Siwen Hu-Lieskovan, Ferry A L M Eskens, Willeke Ros, Adi Diab, Jean-Philippe Spano, Naiyer A Rizvi, Jeffrey S Wasser, Eric Angevin, Patrick A Ott, Alison Forgie, Wenjing Yang, Cen Guo, Jeffrey Chou, Anthony B El-Khoueiry

Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples

优化的液相和气相分离提高了原代细胞和组织样本中HLA肽组的覆盖率

Susan Klaeger ,Annie Apffel ,Karl R Clauser ,Siranush Sarkizova ,Giacomo Oliveira ,Suzanna Rachimi ,Phuong M Le ,Anna Tarren ,Vipheaviny Chea ,Jennifer G Abelin ,David A Braun ,Patrick A Ott ,Hasmik Keshishian ,Nir Hacohen ,Derin B Keskin ,Catherine J Wu ,Steven A Carr

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

针对晚期黑色素瘤、非小细胞肺癌或膀胱癌患者的个性化新抗原疗法联合抗 PD-1 治疗的 Ib 期试验

Patrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, Ramaswamy Govindan, Aung Naing, Nina Bhardwaj, Kim Margolin, Mark M Awad, Matthew D Hellmann, Jessica J Lin, Terence Friedlander, Meghan E Bushway, Kristen N Balogh, Tracey E Sciuto, Victoria Kohler, Samantha J Turnbull, Rana Besada, Riley R Cu

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

联合TCR谱系和血细胞表型可预测黑色素瘤患者对个性化新抗原疗法联合抗PD-1治疗的反应

Asaf Poran ,Julian Scherer ,Meghan E Bushway ,Rana Besada ,Kristen N Balogh ,Amy Wanamaker ,Reid G Williams ,Jasmina Prabhakara ,Patrick A Ott ,Siwen Hu-Lieskovan ,Zakaria S Khondker ,Richard B Gaynor ,Michael S Rooney ,Lakshmi Srinivasan

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

联合TCR谱系和血细胞表型可预测黑色素瘤患者对个性化新抗原疗法联合抗PD-1治疗的反应

Asaf Poran,Julian Scherer,Meghan E Bushway,Rana Besada,Kristen N Balogh,Amy Wanamaker,Reid G Williams,Jasmina Prabhakara,Patrick A Ott,Siwen Hu-Lieskovan,Zakaria S Khondker,Richard B Gaynor,Michael S Rooney,Lakshmi Srinivasan

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy

用于个性化免疫治疗的肿瘤新抗原肽的自动化流式合成

Nicholas L Truex #, Rebecca L Holden #, Bin-You Wang, Pu-Guang Chen, Stephanie Hanna, Zhuting Hu, Keerthi Shetty, Oriol Olive, Donna Neuberg, Nir Hacohen, Derin B Keskin, Patrick A Ott, Catherine J Wu, Bradley L Pentelute

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

聚乙二醇化IL-10(Pegilodecakin)可诱导癌症患者的全身免疫激活、CD8+ T细胞活化和多克隆T细胞扩增

Aung Naing ,Jeffrey R Infante ,Kyriakos P Papadopoulos ,Ivan H Chan ,Cong Shen ,Navneet P Ratti ,Bianca Rojo ,Karen A Autio ,Deborah J Wong ,Manish R Patel ,Patrick A Ott ,Gerald S Falchook ,Shubham Pant ,Annie Hung ,Kara L Pekarek ,Victoria Wu ,Matthew Adamow ,Scott McCauley ,John B Mumm ,Phillip Wong ,Peter Van Vlasselaer ,Joseph Leveque ,Nizar M Tannir ,Martin Oft

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

聚乙二醇化IL-10(Pegilodecakin)可诱导癌症患者的全身免疫激活、CD8+ T细胞活化和多克隆T细胞扩增

Aung Naing,Jeffrey R Infante,Kyriakos P Papadopoulos,Ivan H Chan,Cong Shen,Navneet P Ratti,Bianca Rojo,Karen A Autio,Deborah J Wong,Manish R Patel,Patrick A Ott,Gerald S Falchook,Shubham Pant,Annie Hung,Kara L Pekarek,Victoria Wu,Matthew Adamow,Scott McCauley,John B Mumm,Phillip Wong,Peter Van Vlasselaer,Joseph Leveque,Nizar M Tannir,Martin Oft

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

癌细胞程序促进T细胞排斥和对检查点阻断的耐药性

Livnat Jerby-Arnon ,Parin Shah ,Michael S Cuoco ,Christopher Rodman ,Mei-Ju Su ,Johannes C Melms ,Rachel Leeson ,Abhay Kanodia ,Shaolin Mei ,Jia-Ren Lin ,Shu Wang ,Bokang Rabasha ,David Liu ,Gao Zhang ,Claire Margolais ,Orr Ashenberg ,Patrick A Ott ,Elizabeth I Buchbinder ,Rizwan Haq ,F Stephen Hodi ,Genevieve M Boland ,Ryan J Sullivan ,Dennie T Frederick ,Benchun Miao ,Tabea Moll ,Keith T Flaherty ,Meenhard Herlyn ,Russell W Jenkins ,Rohit Thummalapalli ,Monika S Kowalczyk ,Israel Cañadas ,Bastian Schilling ,Adam N R Cartwright ,Adrienne M Luoma ,Shruti Malu ,Patrick Hwu ,Chantale Bernatchez ,Marie-Andrée Forget ,David A Barbie ,Alex K Shalek ,Itay Tirosh ,Peter K Sorger ,Kai Wucherpfennig ,Eliezer M Van Allen ,Dirk Schadendorf ,Bruce E Johnson ,Asaf Rotem ,Orit Rozenblatt-Rosen ,Levi A Garraway ,Charles H Yoon ,Benjamin Izar ,Aviv Regev